| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 300015.CN | Aier Eye Hospital Group Co., Ltd. Class | 66.2 | $33,131.71 | CN |
| 600436.CN | Zhangzhou Pientzehuang Pharmaceutical Co | 66.7 | $31,799.46 | CN |
| 300122.CN | Chongqing Zhifei Biological Products Co. | 84.6 | $26,013.09 | CN |
| 000661.CN | Changchun High & New Technology Industry | 81.2 | $14,484.74 | CN |
| 300347.CN | Hangzhou Tigermed Consulting Co., Ltd. C | 66.3 | $14,242.65 | CN |
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 300453.CN | Jiang Xi Sanxin Medtec Co Ltd Class A | 79.5 | $590.72 | CN |
| 603987.CN | Shanghai Kindly Enterprises Development | 72.5 | $1,194.10 | CN |
| 002737.CN | Sunflower Pharmaceutical Group Co., Ltd. | 61.5 | $1,356.98 | CN |
| 300401.CN | Zhejiang Garden Bio-chemical High-tech C | 81.6 | $1,387.35 | CN |
| 000915.CN | Shandong Wit Dyne Health Co., Ltd. Class | 83.2 | $1,418.88 | CN |
| Symbol | Name | Grade | Times* | Country |
|---|---|---|---|---|
| 002001.CN | Zhejiang NHU Co. Ltd. Class A | 67.8 | 18 | CN |
| 000661.CN | Changchun High & New Technology Industry | 81.2 | 17 | CN |
| 600436.CN | Zhangzhou Pientzehuang Pharmaceutical Co | 66.7 | 17 | CN |
| 600566.CN | HUBEI JUMPCAN PHARMACEUTICAL CO., LTD Cl | 65.2 | 13 | CN |
| 002252.CN | Shanghai RAAS Blood Products Co., Ltd. C | 74.2 | 12 | CN |
| 300357.CN | Zhejiang Wolwo Bio-Pharmaceutical Co., L | 63.7 | 11 | CN |
| 300015.CN | Aier Eye Hospital Group Co., Ltd. Class | 66.2 | 10 | CN |
| 300482.CN | Guangzhou Wondfo Biotech Co., Ltd. Class | 81.3 | 10 | CN |
| 300595.CN | Ovctek China, Inc. Class A | 71.2 | 9 | CN |
| 600867.CN | Tonghua Dongbao Pharmaceutical Co., Ltd. | 75.7 | 9 | CN |
| Average Market Cap | $7,029.88 |
| Median Market Cap | $3,675.44 |
| Avg. 3 Mo. Dollar Vol. | $77,145,541.29 |
| Avg. 3 Mo. Trading Vol. | 12,406,647 |
| Last Rebalance Date | 06/13/2022 |
| Companies Replaced | 13 |
| Biggest Industry Increase | Health Care |
| Biggest Industry Decrease | Health Care |
| Trailing P/E Ratio (12 Mo.) | 22.8 |
| Forward P/E Ratio (12 Mo.) | 22.68 |
| Price/Book Ratio | 3.98 |
| Avg. Revenue Chg. - 3 Yr | 104.08% |
| Avg. Op. Income Chg. - 3 Yr. | 144.33% |
| Avg. EPS Growth - 3 Yr. | 30.44% |
| Avg. EPS Growth - 1 Yr. | 29.08% |
| Avg. Operating Margin | 25.56% |
| Avg. LT Debt to Total Capital | 11.05% |
| Avg. Return on Equity | 20.37% |
| Dividend Yield | 0.94% |
| MarketGrader China A-Shares Health Care 30 Index | 71.85 |
| China | 100.0% |
